ALEDY yields 40.00% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, ALEDY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALEDY + JNJ for your $10,000?
Allied Group Limited, an investment holding company, engages in the property investment and development, and financial service businesses in Hong Kong, Mainland China, and internationally. The company operates through Investment and Finance, Consumer Finance, Property Development, Property Investment, Property Management, and Elderly Care Services segments. The Investment and Finance segment is involved in the investment activities; and provision of mortgage loan and term loan financing services. The Consumer Finance segment offers consumer SME and other financing products. The Property Development segment engages in the development and sale of properties. The Property Investment segment is involved in the property rental, as well as hotel operations managed by third parties. The Property Management segment provides property management; and cleaning and security guarding. The Elderly Care Services segment elderly care services. The company also offers property holding; securities trading; money lending; consultancy; real estate agency; investment portfolio; corporate; and building management, maintenance, and cleaning services. In addition, it is involved in the medical equipment supplies distribution activities. The company is based in Wan Chai, Hong Kong. Allied Group Limited is a subsidiary of Lee and Lee Trust.
Full ALEDY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.